<p>Seegene Inc Seol Korea based company used newly created artificial intelligence (AI)-based assay development system to develop two multiplexed molecular diagnostics for meningitis and Sexually transmitted Diseases.</p><p>The assays are based on Allplex real-time polymerase chain reaction (PCR) reagents designed to detect eight different DNA targets simultaneously.</p><blockquote class="style-3"><p>The assays are based on Allplex real-time polymerase chain reaction (PCR) reagents designed to detect eight different DNA targets simultaneously.</p></blockquote><p>The Seegene digitized development system automates real-time PCR assay development, driving down the cost of molecular diagnostic tests and enabling nonprofessionals to develop multiplexed assays.</p><p>The company&amp;rsquo;s pipeline of products includes assays that diagnose not only infectious diseases but also drug-resistant pathogens, genetic disorders, and various cancers, including breast, colon, and lung cancers.</p><p><a href="http://www.seegene.com/neo/en/main/main.php">For more information </a></p>